Company Intends to Dramatically Expand Product Offerings into Bioelectronic Treatment of Nausea
CEO to Host Investor Call/Webcast on Wednesday, October 19th at 1:30 PM PT / 4:30 PM ET
Tivic Health® Systems, Inc. (Nasdaq: TIVC) ("Tivic Health"), a commercial-phase health technology company focused on bioelectronic medicine, today announced it has entered into a definitive agreement to acquire the Reliefband product line for nausea treatment and all related assets from Reliefband Technologies, LLC.
Reliefband has been an innovator in wearable, FDA-cleared electronic therapeutics for treatment of nausea and vomiting. Reliefband has multiple products available both over-the-counter and by prescription.
Jennifer Ernst, CEO of Tivic Health, will host an investor conference call/webcast on Wednesday, October 19, 2022, at 1:30 PM PT / 4:30 PM ET.
Teleconference Details:
Toll-Free: 888-506-0062
International: 973-528-0011
Participant Access Code: 533904
Webcast Link:
https://www.webcaster4.com/Webcast/Page/2865/46849
https://finance.yahoo.com/news/tivic-health-acquire-assets-reliefband-123000021.html
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.